Insiders Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 03:31:29 2024-05-02 am EDT			5-day change	1st Jan Change
874 ^DKK	-2.65%		-1.85%	+25.31%

09:15am	News Highlights : Top Company News of the Day - Thursday at 3 AM ET	DJ
08:59am	Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating -- Update	DJ

Germany's Evotec appoints Christian Wojczewski as CEO	Apr. 23	RE
Dpa-AFX Overview: COMPANIES from 25.03.2024 - 15:15	Mar. 25	DP
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions	Mar. 12	MT
WeightWatchers shares drop as Oprah Winfrey decides to exit board	Feb. 29	RE
Novo Nordisk CEO Jorgensen: Demand will outstrip supply for years to come	Feb. 07	MT
Jorgensen, CEO of Novo Nordisk: €10bn investment to meet demand for its weight loss drugs	Jan. 31	MT
Kasim Kutay, CEO of Novo Holdings: Acquisition Offensive	Jan. 19	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	Nov. 27	MT
Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024	Nov. 02	MT
Novo Says Wegovy Is Growth Driver in US	Nov. 02	MT
Recordati, Zdravkovic vice president R&D and Sabia new CMO	23-10-16	AN
Novo Nordisk Halts Ozempic Study	23-10-11	MT
INTERVIEW - PepsiCo CFO Hugh Johnston: Ozempic has no impact on sales	23-10-10	MT
BP Chair Helge Lund Won't Become New Chief Executive	23-09-15	MT
BP Chairman Withdraws from Consideration as Next CEO	23-09-15	MT
Novo-appointed director steps down from ConvaTec board	23-09-08	AN
Novo CEO on Ozempic, Wegovy Demand, Acquisition Strategy	23-09-01	MT
Evaxion Biotech Names Christian Kanstrup as CEO	23-08-29	MT
Catalent to settle with Elliott, explore options -sources	23-08-28	RE
INTERVIEW - Lars Fruergaard Jorgensen, CEO of Novo Nordisk: Treating obesity will be one of our top healthcare priorities	23-08-10	MT